» Articles » PMID: 3859460

HLA-DR Antigens in Primary Biliary Cirrhosis: Lack of Association

Overview
Journal Gut
Specialty Gastroenterology
Date 1985 Jun 1
PMID 3859460
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A study of HLA-DR antigen in 75 patients with primary biliary cirrhosis has been carried out in order to test the hypothesis that genetic factors related to genes controlling immune responses might be important in the pathogenesis of primary biliary cirrhosis. The frequencies of HLA-DR locus antigens was not significantly different from those in 200 normal controls, nor were those of tissue antigens on the A and B loci. No HLA-DR antigen was significantly associated with the appearance of granulomata on liver biopsy (possibly good prognosis) or with raised serum bilirubin (possibly bad prognosis); nor was there any association between any HLA-DR antigen and adverse reactions to D-penicillamine treatment in 17 patients with such adverse reactions. It is concluded that genetic traits related to HLA antigens studied are probably not important in the aetiology of the disease.

Citing Articles

Association of human leukocyte antigen class II with susceptibility to primary biliary cirrhosis: a systematic review and meta-analysis.

Qin B, Wang J, Chen J, Liang Y, Yang Z, Zhong R PLoS One. 2013; 8(11):e79580.

PMID: 24265779 PMC: 3827176. DOI: 10.1371/journal.pone.0079580.


Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving.

Invernizzi P Hepatology. 2011; 54(2):714-23.

PMID: 21563204 PMC: 3145017. DOI: 10.1002/hep.24414.


Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis.

Rong G, Zhong R, Lleo A, Leung P, Bowlus C, Yang G Hepatology. 2011; 54(1):196-203.

PMID: 21488079 PMC: 3125447. DOI: 10.1002/hep.24355.


Genomic variants associated with primary biliary cirrhosis.

Selmi C, Torok N, Affronti A, Gershwin M Genome Med. 2010; 2(1):5.

PMID: 20193050 PMC: 2829930. DOI: 10.1186/gm126.


Genetics and genomics of primary biliary cirrhosis.

Juran B, Lazaridis K Clin Liver Dis. 2008; 12(2):349-65.

PMID: 18456185 PMC: 2685463. DOI: 10.1016/j.cld.2008.02.007.


References
1.
Engleman E, McMichael A, Batey M, McDevitt H . A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J Exp Med. 1978; 147(1):137-46. PMC: 2184102. DOI: 10.1084/jem.147.1.137. View

2.
Miyamori H, Kato Y, Kobayashi K, Hattori N . HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion. 1983; 26(4):213-7. DOI: 10.1159/000198892. View

3.
Doniach D, Roitt I, Walker J, Sherlock S . Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966; 1(3):237-62. PMC: 1579190. View

4.
MITTAL K, Mickey M, Singal D, Terasaki P . Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968; 6(8):913-27. DOI: 10.1097/00007890-196811000-00006. View

5.
Feizi T, Naccarato R, Sherlock S, Doniach D . Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol. 1972; 10(4):609-22. PMC: 1713115. View